본문 바로가기
  • Home

Comparative Study of the Clinical Outcomes of Unilateral Transforaminal Lumbar Interbody Fusion(TLIF) with Bilateral TLIF using Wiltse Approach and Conventional Approach

  • Journal of Korean Society of Spine Surgery
  • Abbr : J Kor Spine Sur
  • 2011, 18(4), pp.208-216
  • Publisher : Korean Society Of Spine Surgery
  • Research Area : Medicine and Pharmacy > Orthopedic Surgery

Ki-Tack KIM 1 손은석 1 KYUNG-SOO Suk ORD ID 1 LEE SANG HUN 1 이정희 1 박경준 1 곽윤호 1 홍세혁 1

1경희대학교

Accredited

ABSTRACT

Study Design: Comparative study. Objectives: To compare the outcomes of unilateral TLIF, bilateral TLIF using Wiltse approach and bilateral TLIF using conventional midline approach. Summary of Literature Review: There are many studies about outcomes of Unilateral TLIF, but few have compared the 3 different fusion procedures. Materials and Methods: 60 patients were divided into 3 groups. Each group has enrolled 20 patients (Study group: unilateral TLIF,Control group 1: bilateral TLIF using Wiltse approach, Control group 2: bilateral TLIF using conventional midline approach). For clinical outcomes, we compared operative time, blood loss, time for ambulation and discharge, VAS for back pain and leg pain and ODI among three groups. For radiologic evaluation, disc height and segmental lordosis were examined. Results: The mean operative time was 147 minutes in study group(SG), 172 minutes in control group 1(CG1), 167 minutes in control group 2(CG2). The mean total blood loss was 466ml in SG, 569ml in CG1, 1140ml in CG2 respectively. VAS for back pain at the third postoperative day significantly decreased in SG and CG1 compared with CG2. There was no significant difference in ODI, disc height and segmental lordosis among the groups. Conclusion: Using Wiltse approach, there were several advantages in decreasing blood loss, immediate postoperative back pain,hospital stay and early ambulation. Clinical and radiological results of unilateral TLIF were comparable with bilateral TLIF.

Citation status

* References for papers published after 2023 are currently being built.